R.D. Bulbrook

4.4k total citations
137 papers, 3.4k citations indexed

About

R.D. Bulbrook is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, R.D. Bulbrook has authored 137 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Genetics, 48 papers in Endocrinology, Diabetes and Metabolism and 45 papers in Oncology. Recurrent topics in R.D. Bulbrook's work include Estrogen and related hormone effects (64 papers), Cancer Risks and Factors (36 papers) and Hormonal and reproductive studies (31 papers). R.D. Bulbrook is often cited by papers focused on Estrogen and related hormone effects (64 papers), Cancer Risks and Factors (36 papers) and Hormonal and reproductive studies (31 papers). R.D. Bulbrook collaborates with scholars based in United Kingdom, Japan and United States. R.D. Bulbrook's co-authors include J.L. Hayward, F. C. Greenwood, B.S. Thomas, C.C. Spicer, D.Y. Wang, J. B. Brown, John W. Moore, Anthony B. Miller, J. L. Hayward and G.M.G. Clark and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

R.D. Bulbrook

136 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.D. Bulbrook United Kingdom 32 1.2k 1.2k 911 533 462 137 3.4k
Janardan D. Khandekar United States 24 1.0k 0.9× 1.3k 1.1× 698 0.8× 532 1.0× 535 1.2× 78 3.3k
Mortimer Levitz United States 37 1.3k 1.1× 695 0.6× 627 0.7× 306 0.6× 1.1k 2.3× 152 4.2k
Olof H. Pearson United States 40 1.8k 1.5× 1.5k 1.3× 1.3k 1.5× 990 1.9× 957 2.1× 136 5.3k
Stener Kvinnsland Norway 30 1.3k 1.1× 1.2k 1.0× 269 0.3× 635 1.2× 734 1.6× 106 3.0k
I. Persson Sweden 26 822 0.7× 687 0.6× 618 0.7× 261 0.5× 516 1.1× 51 2.8k
MC Pike United States 17 789 0.7× 885 0.7× 263 0.3× 401 0.8× 532 1.2× 20 2.3k
J.L. Hayward United Kingdom 37 1.6k 1.4× 2.7k 2.2× 798 0.9× 2.0k 3.7× 630 1.4× 113 5.4k
R. Hähnel Australia 29 1.1k 0.9× 582 0.5× 331 0.4× 416 0.8× 879 1.9× 132 2.6k
Janet L. Stanford United States 26 827 0.7× 1.1k 0.9× 598 0.7× 659 1.2× 783 1.7× 45 3.4k
B E Henderson United States 19 661 0.5× 390 0.3× 770 0.8× 177 0.3× 402 0.9× 29 2.3k

Countries citing papers authored by R.D. Bulbrook

Since Specialization
Citations

This map shows the geographic impact of R.D. Bulbrook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.D. Bulbrook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.D. Bulbrook more than expected).

Fields of papers citing papers by R.D. Bulbrook

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.D. Bulbrook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.D. Bulbrook. The network helps show where R.D. Bulbrook may publish in the future.

Co-authorship network of co-authors of R.D. Bulbrook

This figure shows the co-authorship network connecting the top 25 collaborators of R.D. Bulbrook. A scholar is included among the top collaborators of R.D. Bulbrook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.D. Bulbrook. R.D. Bulbrook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stepniewska, Kasia, D.S. Allen, IS Fentiman, et al.. (1995). Serum prolactin levels and their relationship to survival in women with operable breast cancer. Journal of Clinical Epidemiology. 48(7). 959–968. 23 indexed citations
2.
Stavola, Bianca De, Dennis Y. Wang, Ian S. Fentiman, et al.. (1993). The association of height, weight, menstrual and reproductive events with breast cancer: results from two prospective studies on the island of Guernsey (United Kingdom). Cancer Causes & Control. 4(4). 331–340. 49 indexed citations
3.
Stavola, Bianca De, R.D. Bulbrook, DS Allen, et al.. (1992). Relationship of Blood Prolactin Levels and the Risk of Subsequent Breast Cancer. International Journal of Epidemiology. 21(2). 214–221. 58 indexed citations
4.
Moore, John W., et al.. (1991). Blood concentrations of estradiol and sex hormone-binding globulin in relation to age at menarche in premenopausal British and Japanese women. Breast Cancer Research and Treatment. 18(S1). S47–S50. 18 indexed citations
5.
Overvad, Kim, Dennis Y. Wang, Jørn Olsen, et al.. (1991). Selenium in human mammary carcinogenesis: a case-cohort study. European Journal of Cancer and Clinical Oncology. 27(7). 900–902. 26 indexed citations
6.
Bulbrook, R.D.. (1991). Geographical variation in endocrine function and its relation to breast cancer incidence: Some general considerations. Breast Cancer Research and Treatment. 18(S1). S37–S40. 4 indexed citations
7.
Pike, Malcolm C., et al.. (1991). Cigarette smoking and steroid hormones in women. The Journal of Steroid Biochemistry and Molecular Biology. 39(4). 529–534. 58 indexed citations
8.
Chaudary, M.A., J.L. Hayward, R.D. Bulbrook, et al.. (1991). A comparison of epidemiological characteristics in breast cancer patients and normal women in Great Britain and Japan: Results of a prospective study. Breast Cancer Research and Treatment. 18(S1). S19–S22. 13 indexed citations
9.
Wang, D.Y., Bianca De Stavola, R.D. Bulbrook, et al.. (1988). The permanent effect of reproductive events on blood prolactin levels and its relation to breast cancer risk: a population study of postmenopausal women. European Journal of Cancer and Clinical Oncology. 24(7). 1225–1231. 63 indexed citations
10.
Wang, D.Y., Bianca De Stavola, R.D. Bulbrook, et al.. (1987). The relationship between blood prolactin levels and risk of breast cancer in premenopausal women. European Journal of Cancer and Clinical Oncology. 23(10). 1541–1548. 43 indexed citations
11.
Stewart, John F., R.D. Rubens, Susan Hoare, R.D. Bulbrook, & David Kessel. (1982). Serum sialyl transferase levels in patients with metastatic breast cancer treated by chemotherapy. British Journal of Cancer. 46(2). 208–212. 7 indexed citations
12.
Utsunomiya, Joji, et al.. (1979). Sex hormone-binding globulin and recurrence after mastectomy.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 70(5). 715–6. 2 indexed citations
13.
14.
Thomas, B.S., R.D. Bulbrook, & J.L. Hayward. (1967). Urinary steroid assays and response to endocrine ablation.. BMJ. 3(5564). 523–524. 10 indexed citations
15.
Wang, D.Y., R.D. Bulbrook, & Peter Clifford. (1966). PLASMA-TESTOSTERONE LEVELS IN KENYAN MEN IN RELATION TO CANCER OF THE NASOPHARYNX. The Lancet. 288(7477). 1342–1344. 14 indexed citations
16.
Clifford, Peter & R.D. Bulbrook. (1966). ENDOCRINE STUDIES IN AFRICAN MALES WITH NASOPHARYNGEAL CANCER. The Lancet. 287(7449). 1228–1231. 18 indexed citations
17.
Bulbrook, R.D., J.L. Hayward, C.C. Spicer, & B.S. Thomas. (1962). A COMPARISON BETWEEN THE URINARY STEROID EXCRETION OF NORMAL WOMEN AND WOMEN WITH ADVANCED BREAST CANCER. The Lancet. 280(7268). 1235–1237. 68 indexed citations
18.
Bulbrook, R.D., J.L. Hayward, C.C. Spicer, & B.S. Thomas. (1962). ABNORMAL EXCRETION OF URINARY STEROIDS BY WOMEN WITH EARLY BREAST CANCER. The Lancet. 280(7268). 1238–1240. 85 indexed citations
19.
Bulbrook, R.D., F. C. Greenwood, & J.L. Hayward. (1960). SELECTION OF BREAST-CANCER PATIENTS FOR ADRENALECTOMY OR HYPOPHYSECTOMY BY DETERMINATION OF URINARY 17-HYDROXYCORTICOSTEROIDS AND ÆTIOCHOLANOLONE. The Lancet. 275(7135). 1154–1157. 125 indexed citations
20.
Young, Stretton, R.D. Bulbrook, & F. C. Greenwood. (1957). THE CORRELATION BETWEEN URINARY ŒSTROGEN AND VAGINAL CYTOLOGY. The Lancet. 269(6964). 350–353. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Janardan D. Khandekar Breakdown of academic impact, for papers by Mortimer Levitz Breakdown of academic impact, for papers by Olof H. Pearson Breakdown of academic impact, for papers by Stener Kvinnsland Breakdown of academic impact, for papers by I. Persson Breakdown of academic impact, for papers by MC Pike Breakdown of academic impact, for papers by J.L. Hayward Breakdown of academic impact, for papers by R. Hähnel Breakdown of academic impact, for papers by Janet L. Stanford Breakdown of academic impact, for papers by B E Henderson
Rankless by CCL
2026